Medicines Board backs Seroxat manufacturer’s defence of drug

The Irish Medicines Board today backed claims by the manufacturer of an anti-depressant that the benefits outweighed the risks.

Medicines Board backs Seroxat manufacturer’s defence of drug

The Irish Medicines Board today backed claims by the manufacturer of an anti-depressant that the benefits outweighed the risks.

Norwegian research suggests that adults who take Seroxat are being warned it can trigger suicidal feelings, while Makers GlaxoSmithKline are defending the drug.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited